Telomeres play critical roles in the maintenance of genome integrity and control of cellular senescence. Most eukaryotic telomeres can be transcribed to generate a telomeric repeat-containing RNA (TERRA) that persists as a heterogeneous nuclear RNA and can be developmentally regulated. However, the precise function and regulation of TERRA in normal and cancer cell development remains poorly understood. Here, we show that TERRA accumulates in highly proliferating normal and cancer cells, and forms large nuclear foci, which are distinct from previously characterized markers of DNA damage or replication stress. Using a mouse model for medulloblastoma driven by chronic Sonic hedgehog (SHH) signaling, TERRA RNA was detected in tumor, but not adjacent normal cells using both RNA FISH and Northern blotting. RNA-FISH revealed the formation of TERRA foci (TERFs) in the nuclear regions of rapidly proliferating tumor cells. In the normal developing cerebellum, TERRA aggregates could also be detected in highly proliferating zones of progenitor neurons. SHH could enhance TERRA expression in purified granule progenitor cells in vitro, suggesting that proliferation signals contribute to TERRA expression in responsive tissue. TERFs did not colocalize with γH2AX foci, PML, or Cajal bodies in mouse tumor tissue. We also provide evidence that TERRA is elevated in a variety of human cancers. These findings suggest that elevated TERRA levels reflect a novel early form of telomere regulation during replication stress and cancer cell evolution, and the TERRA RNA aggregates may form a novel nuclear body in highly proliferating mammalian cells.
Summary
Telomeres play critical roles in the maintenance of genome integrity and control of cellular senescence. Most eukaryotic telomeres can be transcribed to generate a telomeric repeat-containing RNA (TERRA) that persists as a heterogeneous nuclear RNA and can be developmentally regulated. However, the precise function and regulation of TERRA in normal and cancer cell development remains poorly understood. Here, we show that TERRA accumulates in highly proliferating normal and cancer cells, and forms large nuclear foci, which are distinct from previously characterized markers of DNA damage or replication stress. Using a mouse model for medulloblastoma driven by chronic Sonic hedgehog (SHH) signaling, TERRA RNA was detected in tumor, but not adjacent normal cells using both RNA FISH and Northern blotting. RNA-FISH revealed the formation of TERRA foci (TERFs) in the nuclear regions of rapidly proliferating tumor cells. In the normal developing cerebellum, TERRA aggregates could also be detected in highly proliferating zones of progenitor neurons. SHH could enhance TERRA expression in purified granule progenitor cells in vitro, suggesting that proliferation signals contribute to TERRA expression in responsive tissue. TERFs did not colocalize with γH2AX foci, PML, or Cajal bodies in mouse tumor tissue. We also provide evidence that TERRA is elevated in a variety of human cancers. These findings suggest that elevated TERRA
Introduction
Telomeres are repetitive DNA structures at the ends of linear chromosomes required for chromosome maintenance and genome stability (Blackburn et al., 2006; Cech, 2004) .
Mammalian telomere DNA consists of variable length double stranded TTAGGG repeats ending in a single stranded 3' overhang that can form complex higher-order nucleoprotein structures to cap chromosome ends (de Lange, 2002; de Lange, 2004) . The telomere-associated proteins, termed shelterin or telosome, are important for telomere end-protection and length regulation Liu et al., 2004; Palm and de Lange, 2008) . In proliferating cells, telomere repeat length is maintained by an elaborate mechanism involving DNA replication machinery, telomerase and its associated factors, and nucleolytic end-processing enzymes (Jain and Cooper, 2011; Ye et al., 2010) . In the absence of telomerase activity, telomeres shorten by attrition, and critically short telomeres elicit a DNA damage signal that can lead to cell cycle arrest and replicative senescence (Sahin and Depinho, 2010) . Loss of telomere capping function leads to cell cycle arrest in normal senescing cells, but this protective mechanism is bypassed in normal proliferating cells and potentially further deregulated in human cancers (Blasco, 2005; Blasco, 2007; .
TERRA is a heterogeneous length non-coding RNA transcribed through the terminal telomere repeats of eukaryotic chromosomes (Azzalin et al., 2007; Schoeftner and Blasco, 2008) . In fission yeast, transcripts can be detected for both sense and anti-sense strands of the telomere repeat tract and adjacent telomere sequence (Bah et al., 2011; Greenwood and Cooper, 2011) . TERRA RNA can interact with shelterin proteins to regulate telomere heterochromatin formation (Deng et al., 2009) and capping by the telomere single strand DNA binding protein Pot 1 (Flynn et al., 2011; Lopez de Silanes et al., 2010) . TERRA can also interact with the catalytic subunit of telomerase (TERT) and inhibit telomerase enzyme activity in vitro (Redon et al., 2010; Schoeftner and Blasco, 2008) . TERRA RNA expression can be regulated by several mechanisms, including developmental status, cellular stress, and telomere epigenetic state (Azzalin et al., 2007; Caslini et al., 2009; Deng et al., 2009; Schoeftner and Blasco, 2008) . In addition, TERRA levels are elevated in both human and mouse iPS cells, suggesting that TERRA Journal of Cell Science Accepted manuscript expression correlates with proliferative capacity and contributes to nuclear reprogramming (Marion et al., 2009; Yehezkel et al., 2011) . However, the expression and function of TERRA in the context of cancer remains poorly understood.
To investigate the regulation and function of TERRA in normal and cancer cell development, we examined TERRA expression in human cancer biopsies and in a mouse model for medulloblastoma. Medulloblastoma is a malignancy of the cerebellum with the highest incidence of all human pediatric malignant brain tumors (Ellison, 2010) . A subset of these tumors is thought to arise from deregulation of granule neuron progenitors (GNPs) development in the cerebellum (Ellison, 2002; Ellison, 2010; Gilbertson, 2004; Gilbertson and Ellison, 2008) . GNPs are subject to very high-rates of proliferation during the early postnatal period. Sonic hedgehog (SHH) is required for the rapid proliferation of these neuronal progenitors during normal development (Dahmane and Ruiz i Altaba, 1999; Wallace, 1999; Wechsler-Reya and Scott, 1999) . Patched 1 (Ptch1) is a receptor for the SHH ligand and an important negative regulator of SHH signaling. Mutations in Ptch1 can lead to medulloblastoma in human (Hahn et al., 1996; Johnson et al., 1996) and mouse models (Goodrich et al., 1997) [reviewed in (Corcoran and Scott, 2001; Ruiz i Altaba et al., 2002) ]. In this work, we show that normal and cancer proliferating granule neuron progenitors express high level of TERRA and exhibit formation of TERRA foci.
These foci (TERFs) are distinct from γH2AX DNA damage foci, but occur in cells where the telomere repeat DNA has shortened. TERRA foci can also be found in highly proliferating progenitor cells during normal mouse development. Finally, we show that TERRA is elevated in various types of human cancers originating in diverse organs.
Results

TERRA form foci in a mouse model for medulloblastoma
To analyze the expression of TERRA in a mouse model of human cancer, we employed Patched1 (Ptch1) +/-mice, a widely used genetic model for human SHH positive subtype medulloblastoma (Ellison, 2010; Goodrich et al., 1997) . These tumors are composed of proliferating GNPs marked by Math1 (e.g (Oliver et al., 2005) , and express Gli1, a target and mediator of the SHH signaling pathway (Goodrich et al., 1997) ( Fig. 1A and S1 ). Tumor can be readily distinguished from normal tissue based on histology and in situ expression analysis of various markers ( Fig. 1A and S1 ). To examine TERRA expression in mouse normal and cancer tissue, we first employed RNA-FISH using methods that have been optimized for detection of rare and unstable RNA (Deng et al., 2009; Flynn et al., 2011) . A TAMRA-conjugated PNA probe was used under non-denaturing conditions to selectively distinguish telomere RNA from telomere DNA. RNA-FISH revealed that TERRA forms discrete foci (TERFs) in the tumor cells, but not in the adjacent non-tumor cells of the same cerebellum (Fig. 1B) . TERFs were not detected in sections pre-treated with RNase A, indicating that the signal detected with the TERRA probe indeed corresponds to RNA expression (Fig. 1B , lower panels and Fig.   S1B ). As an additional specificity control, a FAM-conjugated PNA probe for antisense TERRA failed to detect any distinct foci (Fig. S2B) . Quantification of multiple RNA-FISH experiments using computer imaging software indicated that ~80% of tumor cells have a ~7.5 fold greater mean fluorescence intensity relative to normal cells in adjacent non-tumor tissue ( Fig. 1C-E ). These findings were further confirmed by RNA FISH using a DNA oligonucleotide probe (TAACCC) 7 , which unlike the PNA probe, has very low capacity for binding duplex DNA. The (TAACCC) 7 DNA oligonucleotide probe also revealed elevated TERFs in tumor cells with no detectable signal in the normal part of the same cerebellum (Fig. 1F) . No signal for TERRA expression was observed with a mutated (TAACAC) 7 version of this DNA oligo probe (Fig. 1F) , further indicating that these foci are TERRA-specific and that TERRA levels are selectively elevated in tumor cells.
Elevated TERRA expression in mouse medulloblastoma tissue
To confirm and validate RNA FISH results with other independent techniques, we next examined TERRA expression by Northern blot and quantitative (q)-RT-PCR using RNA isolated from dissected normal (non visible tumor) and tumor regions of Ptch1 +/-cerebella ( Fig. 2 and S3 ). In agreement with the in situ data ( Fig. 1 and Fig. S1 ),
Northern blot analysis indicated that the tumor contained significantly higher levels (~4 fold, p value = 0.0301) of TERRA RNA than the non-tumor counterpart ( Fig. 2A and B, (~6 fold), but a more moderate increases at 2q (1.8 fold) (Fig. 2C, upper panel) . Marker mRNAs for medulloblastoma tumor identity (Math1 and Gli1) and post-mitotic neuronal marker (Map2) were used to confirm the accuracy of dissection (Fig. 2C , bottom panel, Fig. S3B-C) . We also observed that mRNA for the telomerase subunit TERT was not increased in tumor samples (Fig. 2C , lower panel; Fig. S3 ). These results validate findings by RNA FISH, indicating that TERRA is elevated in mouse cancer tissue, and that some, but not all telomeres express high TERRA levels ( Fig. 2B and 2C ).
TERRA is elevated in highly proliferating progenitor cells in the developing mouse brain
Transcriptional profiling analysis have shown that mouse postnatal (P1-P10)
GNPs resemble a subtype of both mouse and human SHH-dependent medulloblastoma (Kho et al., 2004 Fig. 3C -E), in a similar manner to Gli1 and Math1 (Fig. 3F ).
SHH growth factor stimulation increases TERRA levels
To determine whether the growth factor SHH contributes to elevated TERRA expression, we assayed the effect of recombinant SHH on purified primary P5 mouse
GNPs in vitro (Fig. 4) . Using Northern blot analysis, we found that high level of SHH activation (indicated by a large increase in Gli1 expression) following GNPs treatment with recombinant SHH, results in a moderate (~1.3 fold) increase in bulk TERRA levels in GNP cells, as measured by Northern blots (Fig. 4A , B, and S4). By qRT-PCR analysis, we found that TERRA from several different chromosomes increase ~2-3 fold (Fig. 4D ).
To control for SHH activity, we show that SHH treatment of GNPs leads to ~30 fold increase in Gli1 and ~2.5 fold increase in Math1 RNA levels, two bona fide targets of SHH activation in these cells (Fig. 4C ). These findings indicate that TERRA expression can be elevated by high level of SHH signaling in normal GNPs derived from the developing cerebellum.
TERFs form in cells with shortened telomeres
Telomere shortening has been reported to occur in highly proliferative normal and cancer cells (Raynaud et al., 2010; Wentzensen et al., 2011; Xu and Blackburn, 2007) .
To compare the average telomere DNA length in tumor relative to normal cerebellar tissue, we compared the mean average fluorescence intensity of telomere DNA FISH signals. This method can be used to assess the average length of telomere repeat DNA (Baerlocher et al., 2006) . Computer analyzed images of FISH signals showed that in medulloblastoma, telomere repeat signal intensity in tumor tissue was significantly reduced relative to normal tissue ( experiments indicated that ~2.5% of tumor cells contain pan-nuclear γH2AX staining (Fig. 5C ). This is in contrast to the ~80% of tumor cells that contain TERFs (Fig. 1E ).
Among the 2.5% of γH2AX positive cells, we found 80% of these colocalized with strong telomere DNA FISH signals (Fig. 5D ). While small γH2AX foci could also be detected in tumor sections, these foci did not overlap with TERRA RNA or Tel DNA to a significant extent (Fig.S6 , S7, S12). Similarly, TERFs did not overlap with smaller γH2AX foci observed in rapidly dividing normal neurons of developing cerebellum in P6 mice ( Fig. S8 ). Taken together, these findings indicate that TERFs are distinct from TIFs and other γH2AX signals, yet form among the same population of highly proliferative normal and tumor tissue.
TERFs are nuclear foci distinct from PML and Cajal Bodies
To further investigate the subcellular localization of TERFs we examined at higher magnification the confocal images of mouse medulloblastoma tumors ( Fig. 6A and S9A) or normal P5 cerebellar (Fig 6B and S9B) sections after in situ hybridization with a TERRA PNA probe. We observed that TERRA foci typically appear as 1-3 bright foci in the nuclear region of tumor tissue (Fig. 6A ). Fewer and less bright foci were observed in the nucleus of normal P5 cerebellar tissues known to be rapidly dividing (Fig. 6B ). To determine whether TERFs colocalized with other well-characterized nuclear structures, we performed immuno-RNA FISH with antibodies to either PML ( Fig. 6C) , coilin ( Fig. 6D ), or phospho histone H3 (H3pS10) (Fig. 6E ). While TERRA can colocalize with PML in some ALT cell lines (data not shown), we found only few
TERFs that colocalize with PML in mouse medulloblastoma tumor tissue (Fig. 6C ).
Similarly, TERFs rarely colocalized with coilin, which is a marker of Cajal bodies where the telomerase holoenzyme is assembled (Fig. 6D ). Additionally, TERFs were not observed in H3pS10 positive cells, which is a marker for mitotic cells. Thus, TERFs do not colocalize with several well-characterized nuclear structures, and may represent a unique nuclear structure that forms during the interphase of rapidly dividing cells.
TERRA expression is elevated in multiple different human cancer types
To explore whether TERRA levels are elevated in human cancers, we first examined RNA derived from human ovarian tissue diagnosed as either normal, advanced primary tumor, or metastatic tumor ( Fig. 7A-D) . Northern blot analysis indicated that most of the ovarian primary and metastatic tumors expressed higher levels of TERRA than otherwise normal ovarian tissue ( Fig. 7A-B) . Chromosome-specific qRT-PCR analysis also confirmed that primary and metastatic tumors had higher levels of TERRA at most, but not all subtelomeres tested relative to the normal tissue ( Fig. 7C-D) . In one sample derived from normal ovarian tissue, we observed very high levels of TERRA by
Northern blot (Fig. S10A) . However, upon further molecular characterization of these tissues, this sample (HR406) was found to express levels of the proliferation marker Ki67 that were >50 fold relative to two other normal ovarian tissue, and 3-5 fold greater than advanced primary or metastatic tumors (Fig. S10B ), indicating that this ovarian tissue was highly proliferative. This further supports the correlation between cell proliferation state and elevated TERRA levels. To further investigate whether TERRA was elevated in other human cancer tissues, we compared TERRA expression in primary human tumors and matched normal tissue controls derived from various cancer biopsies, including those derived from stomach, lung, and colon ( Fig. 7E-H) . Northern blot analyses showed that TERRA is expressed at higher levels in tumor-derived tissues relative to matched control tissues ( Fig. 7E and S9A ). Anti-sense TERRA was not detected when the same Northern blot was stripped and reprobed with G-rich probe,
indicating that the telomere RNA species is strand-specific (Fig. 7E , right panel, and Fig.   S11 ). TERRA expression was also analyzed by chromosome-specific qRT-PCR for several different telomeres ( Fig. 7F-H) . The cell proliferation marker Ki67 was used as a control for tumor dissection, and was elevated ~6-100 fold relative to normal matched tissue RNA. Consistent with Northern blotting data, we found that TERRA RNA was elevated in tumor tissue relative to matched control tissue for most subtelomeres tested.
However, only a few subtelomeres showed significantly (>4 fold) higher TERRA levels in tumor tissue relative to normal, and no particular subtelomere showed elevated TERRA consistently for all the tumor samples. For example, only telomere 13q expressed high (>4 fold) TERRA levels in one stomach cancer biopsy, while 17q and 2q
were elevated in lung, and 10q and 17q elevated in a colon carcinoma biopsy. No one subtelomere was consistently elevated for TERRA expression, even when tumors were derived from the same organ (data not shown). These results indicate that TERRA expression is elevated in various human cancer tissues, and can be expressed from a few chromosomes, which may vary among cell and cancer types.
Discussion
We show here that in mammalian cells in vivo, TERRA expression is linked to the proliferative and tumorigenic state of the cell. We found that TERRA levels were elevated in highly proliferating normal and cancer cells in both mouse tissue sections and human cancer biopsies. Using a well-established mouse model of brain cancer (i.e. medulloblastoma), we found that TERRA RNA was elevated in tumor, but not in normal cerebellar tissue (Figs. 1-2, S1-S3). RNA FISH revealed pronounced TERRA foci, termed TERFs, in cells over-expressing TERRA RNA. TERFs were sensitive to RNase A and not detected with control probes containing a mutation in the telomere repeat sequence, indicating that these were indeed TERRA-containing foci. Furthermore, TERFs appeared only in tissues where high level TERRA expression was validated by
Northern blot and qRT-PCR ( Fig. 2 and S3 ). TERFs generally formed as one or few major foci in the nuclear region of proliferating cells. TERRA and TERFs were also elevated in rapidly dividing progenitor cells of the developing cerebellum, indicating that normal proliferating cells can also form TERFs (Fig. 3) . TERRA levels were also enhanced by addition of recombinant SHH growth factor to purified progenitor cells in vitro, suggesting that strong and chronic growth factor stimulation promotes TERRA accumulation ( Fig. 4 and S4 ). TERFs formed in the same cell populations where γH2AX DNA damage foci form (Fig. 5, S6 , S7, and S12) and telomere DNA shortening has occurred ( Fig. S5 ), but TERFs did not colocalize with γH2AX foci (Fig. 5 ), nor with PML or Cajal nuclear bodies (Fig. 6 ). Finally, we provide evidence that TERRA is expressed at higher levels in many human cancer tissues relative to matched controls ( Fig. 7 and S10 ). These findings support the model that TERRA expression is coupled to cellular proliferation and that TERFs are a novel indicator of proliferative stress.
Our results are different from several previous reports that described either a decrease in TERRA expression between normal and colon cancer (Schoeftner and Blasco, 2008) , diminished TERRA in advanced astrocytoma (Sampl et al., 2012) or a lack of expression in cancer cell lines (Ng et al., 2009; Zhang et al., 2009 ). The differences may reside in the use of tumor tissue compared to cancer cell lines (Ng et al., 2009; Zhang et al., 2009) as well as in the techniques used to detect TERRA expression [a comprehensive use of RNA-FISH, Northern and qRT-PCR in our study as opposed to dot blot in (Schoeftner and Blasco, 2008) or quantitative RT-PCR from few chromosomes (Sampl et al., 2012) ]. It is also likely that TERRA expression in human cancers may be regulated in a more complex manner corresponding to the patient history, cancer type, and tumor tissue integrity. In our experiments, human tumor RNA was purified from freshly isolated unfixed biopsies to avoid RNA degradation. Our use of a mouse cancer model has also enabled us to examine adjacent non-tumor and tumor tissue on the same section. In mouse model of medulloblastoma, we were able to utilize methods developed for RNA FISH that reduce the time of fixation and denaturation that commonly degrade or modify RNA. Together, these methods have allowed us to observe TERRA expression and localization in tissue sections and isolates that better preserve the in vivo physiology of cellular proliferation and cancer.
The function and regulation of TERRA has been explored in several previous studies (Azzalin et al., 2007; Deng et al., 2009; Redon et al., 2010; Schoeftner and Blasco, 2008) . We have previously shown that TERRA can protect telomere ends from DNA damage signaling by promoting telomeric heterochromatin formation (Deng et al., 2009 ). TERRA has also been shown to inhibit telomerase activity in vitro (Redon et al., 2010; Schoeftner and Blasco, 2008) . TERRA levels can be elevated in cell lines lacking DNA methyltransferase 3b (DNMT3b) (Yehezkel et al., 2008) , as well as in response to developmental and stress signals (Schoeftner and Blasco, 2008) . Our data suggests that TERRA expression can be enhanced by growth factor signaling (e.g. SHH) and cell proliferation in vivo. Moreover, chronic proliferation signals associated with carcinogenic mutations (like Ptch1 +/-) lead to elevated TERRA and TERF formation. We also observed that telomere DNA signal decreases (Fig. S5 ) and that TERT mRNA levels are not elevated ( Fig. 2 and S3 ) in tumor tissue. We propose that TERRA is required for telomere end processing and protection during normal cell proliferation, and that elevated TERRA and TERF protects telomeres from eliciting a DNA damage response during conditions of proliferative stress (Fig. 8 ).
γH2AX-positive DNA damage foci have been shown to be elevated in highly proliferating cells and precancerous lesions (Bartkova et al., 2005; Gorgoulis et al., 2005; Jackson and Bartek, 2009) . We found that small γH2AX foci accumulate in mouse medulloblastoma, with ~2.5% of the tumor cells containing pan-nuclear γH2AX foci (Fig. 5) . In contrast, ~80% of these cells were TERF positive. Importantly, most γH2AX
foci did not overlap with TERFs, but did colocalize with telomere DNA foci (TIFs).
Others have shown that telomere DNA forms aggregates in highly proliferating cancer cells (Mai and Garini, 2006) . Unfortunately, we were unable to colocalize TERFs with telomere DNA signals, so can not exclude the possibility that TERFs are expressed at telomere aggregates in highly proliferating cells. We did find that telomeres were generally shorter in mouse cancer cells that express TERRA and form TERFs (Fig. S5) , suggesting that short telomeres may promote TERRA transcription activation. Elevated TERRA expression in highly proliferating cancer and normal progenitor cells may stabilize these abnormally short telomeres, perhaps through inhibition of the DNA damage response. This is consistent with the observed lack of DNA damage associated γH2AX-foci colocalizing with TERFs (Fig. 5, S6 and S7). TERRA may prevent DNA damage response at short telomeres by stabilizing the shelterin complex, heterochromatin formation, or protection of single stranded telomeric DNA (Deng et al., 2009; Flynn et al., 2011) .
TERRA foci and telomeric transcript accumulations (Tacs) have been described previously (Azzalin et al., 2007; Marion et al., 2009; Schoeftner and Blasco, 2008; Zhang et al., 2009) . In human cell lines, TERRA can colocalizes to metaphase telomeres and form variable numbered foci that can be upregulated by depleting components of the nonsense mediated decay (NMD) pathway (Azzalin et al., 2007) . In undifferentiated mouse ES cells, Tacs associate with both sex-chromosome, but upon ES cell differentiation, Tacs relocalize to the inactive X chromosome in females or the Y-chromosome in males (Schoeftner and Blasco, 2008) . In telomerase-deficient TRF2-overexpressing (K5TRF2/TERC -/-) mouse models of telomere dysfunction, Tacs delocalize from the inactive X-chromosome, reflecting a novel form of telomere dysfunction ). While we did not directly examine the localization of TERFs with respect to the inactive X chromosome, the TERFs that we observe in rapidly proliferating cells are likely to be very similar to Tacs. However, since Tacs have not been reported to be elevated in rapidly proliferating progenitor neurons or medulloblastoma, we refrain from concluding that these TERFs and Tacs are identical structures.
RNA mediated nuclear body formation has been observed for a variety of other RNA species (Shevtsov and Dundr, 2011) . Transcription of the tandem arrays of satellite III (sat III) repetitive DNA is known to form nuclear stress bodies located at pericentromeric DNA (Biamonti and Vourc'h, 2010) . Recent genome-wide sequencing studies have found that satellite repeat transcripts were aberrantly overexpressed in various human and mouse epithelial cancers (Ting et al., 2011) . While, Sat III repeat DNA and RNA have some intriguing similarities with TERRA DNA and RNA, we did not observe that TERFs had similar patterns of granulation commonly seen with SatIII nuclear stress bodies in tissue culture cell lines. However, it will be important to determine if TERF positive tumor tissue is also enriched in Sat III nuclear bodies, and whether these structures share common features with TERFs. TERFs may also share features with other RNAnucleated bodies, including the miRNA processing P-bodies (Parker and Sheth, 2007) and cytoprotective aggresomes (Wileman, 2007) . In some cancer cells, telomere DNA has been shown to aggregate in conjunction with nuclear lamina (Mai and Garini, 2006; Raz et al., 2008) . In contrast to TERFs, telomere aggregates colocalize with γH2AX
DNA damage foci, suggesting that these are distinct nuclear structures (Raz et al., 2008 ).
Nevertheless, it is possible that TERFs reflect a cluster of several highly transcribed telomeres that correspond to the telomere aggregates observed in some cancer types.
TERFs did not show significant colocalization with other well-characterized nuclear structures, including coilin-containing Cajal bodies or PML-containing ND10 bodies (Fig. 6) . Thus, TERFs appear to represent a unique nuclear body formed by TERRA accumulation from one or more telomeres in highly proliferating cells.
An important unanswered question is how TERRA expression, processing, and localization may differ in normal differentiated, normal proliferating, and abnormal cancer cells. TERRA levels and TERFs can be detected in both proliferating cell types, although we did observe greater TERRA processing to several smaller RNA species ( Fig.   7 and S10) and an average greater density of TERFs in cancer tissue relative to progenitor cells (Figs. 2 and 6 ). It may not be surprising that progenitor cells have similar TERRA expression patterns as cancer cells, since they are known to share common gene expression profile as in the case of medulloblastoma (Kho et al., 2004) .
We suggest that the major difference between cancer and progenitor cells is the abnormal prolonged exposure to proliferation signals and the potential stabilization of shortened and damaged telomeres through the action of TERRA. We also observed TERF expression is highly elevated in human cancer cell lines with ALT elongated telomeres, as observed in U2OS cells (Fig. S15) . It is therefore possible that TERRA expression in mouse medulloblastoma correlates with the ALT phenotype, but additional experiments are needed to confirm this possibility. While the precise function, processing, and localization of TERFs remains unknown, these details will be essential for understanding the regulation of telomeres during normal and cancer cell proliferation. In summary, our data demonstrates that TERRA accumulates and forms TERFs in highly proliferating progenitors and cancer tissue, and suggests that TERFs may provide a novel and sensitive biomarker for telomere dysfunction in cancer.
Materials and Methods
Mouse breeding. Medulloblastoma used in our study formed in the Ptch1 +/-colony either alone or in combination with p53 -/+ . The tumor 6850 (Fig. 1A) Telomeric RNA FISH on tissue section. Tissue sections (7 to 12 microns) were prepared as described previously (Fernandez et al., 2010) , with the modifications indicated in supplementary methods. Hybridization was performed overnight at 37 °C, and the following probes were used in the hybridization: a Tamra of total RNA as manufacturer's instructions. A specific primer (CCCTAA) 6 was used to obtain TERRA cDNA at 55˚C. Real-time PCR experiments were performed as described (Deng et al., 2009) . Relative RT-PCR was determined using ΔΔCT methods relative to control samples and internal control Actin and Gapdh for human samples or Gapdh for mouse samples. Primer sequences used for real time PCR are listed in supplemental Table   I .
Telomere DNA FISH. Tissue sections were prepared essentially as described in RNA FISH method section. Telomeric DNA FISH was performed as followings. After acetylation, sections were subject to RNase A treatment by the incubation in PBST with 100 ug/ml RNase A for 30-60 mins at 37 °C. Sections were washed three times in PBS, and dehydrated in cold ethanol series 5 mins for each (70%, 95%, 100%). Slides with sections were denatured on a 80-85 °C hot plate for 5 mins in the presence of about 120 μl of hybridization mix (70% formamide, 10 mM TRis-HCl pH 7.2, 0.5% blocking reagent) containing telomeric PNA-Tamra-(CCCTAA) 3 probe, and hybridization was performed in the dark for overnight at room temperature. The slides were washed two times 15 mins each in 70% formamide, 10 mM Tris-HCl, pH 7.2, 0.1% BSA followed by three times 5 mins each in 0.1 M Tris-HCl, pH 7.2, 0.15 M NaCl, 0.08% Tween-20, stained with 0.1 μg/ml DAPI, and mounted in mounting medium. Confocal images were taken with Zeiss LSM510META NLO laser scanning confocal system on a Zeiss
Axiovert 200M inverted microscope with Zeiss AIM Ver.4.0 software and Adobe PhotoShop CS5 for image processing. Image capture and quantification process were performed in the same methods as that in RNA-FISH.
For combined γH2AX staining and FISH analysis, we performed RNA or DNA FISH as described above. After washes, the sections were fixed again in 4% paraformaldehyde for 15 mins, blocked in blocking solution (1 mg/ml BSA, 3% goat serum, 0.1% Triton X-100, 1 mM EDTA in PBS) for at least 30 mins, and incubated with γH2AX monoclonal antibody (Upstate) diluted in blocking solution (1:100) for 1 hr at room temperature. The sections were washed three times with PBST for 5 mins each, and incubated with Alexa 488 conjugated secondary antibody (2mg/ml stock solution diluted 1:600 in PBST) in blocking solution for 30 mins. The sections were further washed with PBST, counter stained with DAPI, and mounted in mounting medium before confocal microscope.
Rabbit polyclonal antibodies to Coilin (H-300) and phospho-Histone H3 (Ser10) were purchased from Santa Cruz and Millipore, respectively. Monoclonal antibody to mouse PML was a gift from Dr. Olga Vladimirova at the Wistar Institute.
Granule neuron progenitor purification
Granule neuron progenitors (GNPs) were purified from P5 mouse cerebella as described in (Fernandez et al., 2010) . SHH (600ng/ml, R&D) was added to the media for 12 hours.
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